Oguzhan Alagöz

According to our database, Oguzhan Alagöz authored at least 19 papers between 2003 and 2023.

Collaborative distances:

• Dijkstra number of four.
• Erdős number of four.

2023

Personalized Disease Screening Decisions Considering a Chronic Condition.

Ali Hajjar, Oguzhan Alagöz

Manag. Sci., January, 2023

2021

Reflecting on 20 years of breast cancer modeling in CISNET: Recommendations for future cancer systems modeling efforts.

Amy Trentham-Dietz, Oguzhan Alagöz, Christina Chapman, Xuelin Huang, Jinani Jayasekera, Nicolien T. van Ravesteyn, Sandra J. Lee, Clyde B. Schechter, Jennifer M. Yeh, Sylvia K. Plevritis, Jeanne S. Mandelblatt, Breast Working Group of the Cancer Intervention, Surveillance Modeling Network (CISNET)

PLoS Comput. Biol., 2021

2016

Heterogeneity in Women's Adherence and Its Role in Optimal Breast Cancer Screening Policies.

Turgay Ayer, Oguzhan Alagöz, Natasha K. Stout, Elizabeth S. Burnside

Manag. Sci., 2016

2015

Optimally solving Markov decision processes with total expected discounted reward function: Linear programming revisited.

Oguzhan Alagöz, Mehmet U. S. Ayvaci, Jeffrey T. Linderoth

Comput. Ind. Eng., 2015

2014

Optimizing Colonoscopy Screening for Colorectal Cancer Prevention and Surveillance.

Fatih Safa Erenay, Oguzhan Alagöz, Adnan Said

Manuf. Serv. Oper. Manag., 2014

Healthcare Intelligence: Turning Data into Knowledge.

Hui Yang, O. Erhun Kundakcioglu, Jing Li, Teresa Wu, Joseph Ross Mitchell, Amy K. Hara, William Pavlicek, Leland S. Hu, Alvin C. Silva, Christine M. Zwart, Sait Tunç, Oguzhan Alagöz, Elizabeth S. Burnside, W. Art Chaovalitwongse, Georgiy Presnyakov, Yulian Cao, Sirirat Sujitnapitsatham, Daehan Won, Tara M. Madhyastha, Kurt E. Weaver, Paul R. Borghesani, Thomas J. Grabowski, Lianjie Shu, Man Ho Ling, Shui Yee Wong, Kwok-Leung Tsui

IEEE Intell. Syst., 2014

A survey of optimization models on cancer chemotherapy treatment planning.

Jinghua Shi, Oguzhan Alagöz, Fatih Safa Erenay, Qiang Su

Ann. Oper. Res., 2014

2013

A Comprehensive Methodology for Determining the Most Informative Mammographic Features.

Yirong Wu, Oguzhan Alagöz, Mehmet Ayvaci, Alejandro Munoz del Rio, David J. Vanness, Ryan S. Woods, Elizabeth S. Burnside

J. Digit. Imaging, 2013

Optimal Policies for Reducing Unnecessary Follow-Up Mammography Exams in Breast Cancer Diagnosis.

Oguzhan Alagöz, Jagpreet Chhatwal, Elizabeth S. Burnside

Decis. Anal., 2013

2012

The Effect of Budgetary Restrictions on Breast Cancer Diagnostic Decisions.

Mehmet Ayvaci, Oguzhan Alagöz, Elizabeth S. Burnside

Manuf. Serv. Oper. Manag., 2012

OR Forum - A POMDP Approach to Personalize Mammography Screening Decisions.

Turgay Ayer, Oguzhan Alagöz, Natasha K. Stout

Oper. Res., 2012

A Broader View of Designing the Liver Allocation System.

Mustafa Akan, Oguzhan Alagöz, Baris Ata, Fatih Safa Erenay, Adnan Said

Oper. Res., 2012

2010

Optimal Breast Biopsy Decision-Making Based on Mammographic Features and Demographic Factors.

Jagpreet Chhatwal, Oguzhan Alagöz, Elizabeth S. Burnside

Oper. Res., 2010

Modeling secrecy and deception in a multiple-period attacker-defender signaling game.

Jun Zhuang, Vicki M. Bier, Oguzhan Alagöz

Eur. J. Oper. Res., 2010

2008

Estimating the Patient's Price of Privacy in Liver Transplantation.

Burhaneddin Sandikçi, Lisa M. Maillart, Andrew J. Schaefer, Oguzhan Alagöz, Mark S. Roberts

Oper. Res., 2008

2007

Choosing Among Living-Donor and Cadaveric Livers.

Oguzhan Alagöz, Lisa M. Maillart, Andrew J. Schaefer, Mark S. Roberts

Manag. Sci., 2007

Determining the Acceptance of Cadaveric Livers Using an Implicit Model of the Waiting List.

Oguzhan Alagöz, Lisa M. Maillart, Andrew J. Schaefer, Mark S. Roberts

Oper. Res., 2007

2004

The Optimal Timing of Living-Donor Liver Transplantation.

Oguzhan Alagöz, Lisa M. Maillart, Andrew J. Schaefer, Mark S. Roberts

Manag. Sci., 2004

2003

Rescheduling of identical parallel machines under machine eligibility constraints.

Oguzhan Alagöz, Meral Azizoglu

Eur. J. Oper. Res., 2003